2023 International Congress

August 27-31, 2023. Copenhagen, Denmark.

View by Title View Categories

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Is STN a good target for decrease off period by DBS, Gpi – for reduction of dyskinesia in PD patients?

A. Buniak, V. Alexeyevets, S. Likhachev, V. Bayarchyk (Minsk, Belarus)
Is there a common structural network for stimulation-induced dysarthria in subthalamic and thalamic deep brain stimulation?

JN. Petry-Schmelzer, H. Jergas, T. Thies, JC. Baldermann, V. Visser-Vandewalle, TA. Dembek, MT. Barbe (Cologne, Germany)
Is there impairment in neuromuscular trunk control in Parkinson disease when compared to healthy elderly?

H A. Araújo, A. Melanda, R. da Silva, S. Smaili (Londrina, Brazil)
Is working memory training success in Parkinson’s disease determined by cortical thickness and white matter lesions?

K. Giehl, H. Theis, A. Ophey, J. Hammes, P. Reker, C. Eggers, E. Kalbe, T. van Eimeren (Cologne, Germany)
Isolated vocal tremor: a case series

J. Bundy, Y. Kianirad (Chicago, USA)
Isolated ZIC-4 antibody associated cerebellar dysfunction triggered by Tuberculosis

S. Garg, K. Shetty, S. Agrawal (Bengaluru, India)
Isolation of L1CAM-extracellular vesicles reveals signs of insulin resistance in Parkinson’s disease

I. Markaki, W. Paslawski, T. Ntetsika, P. Svenningsson (Stockholm, Sweden)
Istradefylline effect on Parkinson’s Disease Tremor, Motor symptoms and non-Motor symptoms.

K. Chandrakumar, B. Wilmarth, B. Nagle, G. Di Maria, O. Gonul, L. Lovelace, E. Waldon, K. Getchell, Y. Torres-Yaghi, F. Pagan (Washington, USA)
Istradefylline therapy for PD plus oromandibular dystonia

NAO. Kanzato, SAT. Mochizuki (Haearu-cho, Okinawa, Japan)
Jaw opening myoclonus in Subacute Sclerosing Panencephalitis: A new phenotypic observation which may be a diagnostic clue

D. Garg, S. Sharma (New Delhi, India)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z